| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
| 体型 | 平均 |
この研究の注釈：
The addition of 400 µg chromium (as picolinate) to antipsycotic therapy in a small sample of schizophrenic persons over three months failed to significantly influence symptoms of schizophrenia relative to control as assessed by PANSS and HAM-D rating scales.